Comparing Two Indirect Pulp Capping Agents for Permanent Teeth
Launched by CAIRO UNIVERSITY · Jun 15, 2022
Trial Information
Current as of June 25, 2025
Unknown status
Keywords
ClinConnect Summary
Indirect pulp treatment has become a common maneuver in vital pulp therapy in recent years and is a procedure performed in teeth with deep carious lesions approximating the pulp but without any signs or symptoms of irreversible pulpal changes.
Silver Diamine Fluoride is used to arrest caries lesions in primary teeth but according to the AAPD,2021 more research is needed on the use of SDF to arrest caries lesions in permanent teeth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient and parent showing cooperation and compliance.
- • Children 9-14 years old
- • Vital deeply carious young first permanent molar(s) with complete root formation
- • Asymptomatic teeth or without clinical symptoms of spontaneous pain
- • Both genders will be included.
- Exclusion Criteria:
- • Children unable to return for recall visits.
- • Any clinical signs of irreversible pulpitis or pulp necrosis (spontaneous pain, pain on percussion, abscess, sinus).
- • Any radiographic sign of irreversible pulp pathologies or pulp necrosis (periapical radiolucency, internal or external root resorption)
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Manal Ahmed El Sayed
Principal Investigator
Professor of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University
Randa Youssef Abd Al Gawad
Principal Investigator
Professor of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials